SEC Comment Letter for MDxHealth SA (MDXH) — Jan 6, 2026
MDxHealth SA
Date: Jan. 6, 2026 · CIK: 0001872529 · Accession: 0000000000-26-000102
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292463
Letter
Re: MDxHealth SA Registration Statement on Form F-3 Filed December 29, 2025 File No. 333-292463 Dear Michael McGarrity:
January 6, 2026
Michael McGarrity Chief Executive Officer MDxHealth SA CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Mark Busch, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> January 6, 2026 Michael McGarrity Chief Executive Officer MDxHealth SA CAP Business Center Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium Re: MDxHealth SA Registration Statement on Form F-3 Filed December 29, 2025 File No. 333-292463 Dear Michael McGarrity: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Mark Busch, Esq. </TEXT> </DOCUMENT>